Cargando…
MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis
The emergence of Plasmodium falciparum resistant to frontline therapeutics has prompted efforts to identify and validate agents with novel mechanisms of action. MEPicides represent a new class of antimalarials that inhibit enzymes of the methylerythritol phosphate (MEP) pathway of isoprenoid biosynt...
Autores principales: | Edwards, Rachel L., Brothers, Robert C., Wang, Xu, Maron, Maxim I., Ziniel, Peter D., Tsang, Patricia S., Kraft, Thomas E., Hruz, Paul W., Williamson, Kim C., Dowd, Cynthia S., John, Audrey R. Odom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567135/ https://www.ncbi.nlm.nih.gov/pubmed/28827774 http://dx.doi.org/10.1038/s41598-017-07159-y |
Ejemplares similares
-
Potent, specific MEPicides for treatment of zoonotic staphylococci
por: Edwards, Rachel L., et al.
Publicado: (2020) -
Five Questions about Non-Mevalonate Isoprenoid Biosynthesis
por: Odom, Audrey R.
Publicado: (2011) -
On the Origin of Isoprenoid Biosynthesis
por: Hoshino, Yosuke, et al.
Publicado: (2018) -
FR-900098, an antimalarial development candidate that inhibits the non-mevalonate isoprenoid biosynthesis pathway, shows no evidence of acute toxicity and genotoxicity
por: Wiesner, Jochen, et al.
Publicado: (2016) -
Muddled mechanisms: recent progress towards antimalarial target identification
por: Edwards, Rachel L., et al.
Publicado: (2016)